Company Overview of Pernix Sleep, Inc.
Pernix Sleep, Inc., a specialty pharmaceutical company, engages in developing and commercializing prescription therapeutics to treat medical conditions. The company focuses on in-licensing, developing, and marketing proprietary products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area. Its products include Silenor, a nonscheduled prescription medication for the treatment of sleep maintenance insomnia, which include adults and the elderly who have sleep maintenance insomniaA type of insomnia, people with chronic sleep maintenance insomnia (insomnia lasting more than three weeks), and people with transient insomnia. Th...
10935 Vista Sorrento Parkway
San Diego, CA 92130
Founded in 2003
Key Executives for Pernix Sleep, Inc.
Senior Vice President of Technical Operations
Compensation as of Fiscal Year 2014.
Pernix Sleep, Inc. Key Developments
Pernix Sleep, Inc., Annual General Meeting, Jun 19, 2013
Apr 26 13
Pernix Sleep, Inc., Annual General Meeting, Jun 19, 2013., at 11:00 US Eastern Standard Time. Location: Pernix Therapeutics Holdings, Inc.. Agenda: To elect five directors for a term of one year; to approve, on an advisory basis, the company's executive compensation; to indicate, on an advisory basis, how frequently the company should hold an advisory vote on executive compensation; to ratify the selection of Cherry Bekaert LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2013; and to transact such other business as may properly come before the meeting or any postponement or adjournment thereof.
Somaxon Pharmaceuticals, Inc. Amends and Restates in its Certificate of Incorporation
Mar 12 13
Somaxon Pharmaceuticals, Inc. was amended and restated in its entirety to be substantially identical to the certificate of incorporation of merger sub as in effect immediately prior to the effective time of acquisition, except that the name of Somaxon became Pernix Sleep, Inc. Additionally, pursuant to the merger agreement, at the effective time, the bylaws of merger sub became the bylaws of Somaxon, except that the bylaws were amended to replace all references to Pernix Acquisition Corp. I with references to Pernix Sleep, Inc.
Somaxon Pharmaceuticals, Inc.(NasdaqCM:SOMX) dropped from NASDAQ Composite Index
Mar 6 13
Somaxon Pharmaceuticals, Inc. will be removed from NASDAQ Composite Index .
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|